Old Web
English
Sign In
Acemap
>
authorDetail
>
Falk Dillmann
Falk Dillmann
German Cancer Research Center
Immunology
Medicine
Chronic myelogenous leukemia
CXCR4
Imatinib
3
Papers
65
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib.
2009
Leukemia & Lymphoma
Falk Dillmann
M.R. Veldwijk
Stephanie Laufs
Markus Sperandio
Gary Calandra
Frederik Wenz
W. Jens Zeller
Stefan Fruehauf
Show All
Source
Cite
Save
Citations (60)
AMD3100 Inhibits Chemotaxis towards SDF-1 and CXCR4-Mediated Stroma-Contact in a Dose-Dependent Manner, Resulting in Increased Susceptibility to Imatinib.
2006
Blood
Falk Dillmann
Marlon R. Veldwijk
Gary Calandra
Werner J. Zeller
Anthony D. Ho
Stefan Fruehauf
Show All
Source
Cite
Save
Citations (1)
The CXCR4-Antagonist AMD3100 Augments the Number of Mobilized Peripheral Blood Progenitor Cells (PBPC) When Added to a G-CSF Standard Mobilization Regime and AMD3100-Mobilized PBPC Result in Rapid Hematopoietic Reconstitution after Autologous Transplantation.
2005
Blood
Stefan Fruehauf
Timon Seeger
Julian Topaly
Doris Herrmann
Falk Dillmann
Per Humpert
Gary Calandra
Stephanie Laufs
Hartmut Goldschmidt
Anthony D. Ho
Show All
Source
Cite
Save
Citations (4)
1